Literature DB >> 6756493

A review of some statistical methods for covariance analysis of categorical data.

G G Koch, I A Amara, G W Davis, D B Gillings.   

Abstract

Three general methods for covariance analysis of categorical data are reviewed and applied to an example from a clinical trial in rheumatoid arthritis. The three methods considered are randomization-model nonparametric procedures, maximum likelihood logistic regression, and weighted least squares analysis of correlated marginal functions. A fourth heuristic approach, the unweighted linear model analysis, is an approximate procedure but it is easy to implement. The assumptions and statistical issues for each method are discussed so as to emphasize philosophical differences between their rationales. Attention is given to computational differences, but it is shown that the methods lead to similar results for analogous problems. It is argued that the essential differences between the methods lie in their underlying assumptions and the generality of the conclusions which may be drawn.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6756493

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  12 in total

1.  Antibody response to Cryptococcus neoformans proteins in rodents and humans.

Authors:  L C Chen; D L Goldman; T L Doering; L a Pirofski; A Casadevall
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

2.  Behavioral evidence for host races in Rhagoletis pomonella flies.

Authors:  Ronald J Prokopy; Scott R Diehl; Sylvia S Cooley
Journal:  Oecologia       Date:  1988-06       Impact factor: 3.225

3.  Sensitivity analysis for missing outcomes in time-to-event data with covariate adjustment.

Authors:  Yue Zhao; Benjamin R Saville; Haibo Zhou; Gary G Koch
Journal:  J Biopharm Stat       Date:  2015-01-30       Impact factor: 1.051

4.  Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series.

Authors:  Sudha S Shankar; Adrian Vella; Ralph H Raymond; Myrlene A Staten; Roberto A Calle; Richard N Bergman; Charlie Cao; Danny Chen; Claudio Cobelli; Chiara Dalla Man; Mark Deeg; Jennifer Q Dong; Douglas S Lee; David Polidori; R Paul Robertson; Hartmut Ruetten; Darko Stefanovski; Maria T Vassileva; Gordon C Weir; David A Fryburg
Journal:  Diabetes Care       Date:  2016-07-12       Impact factor: 19.112

5.  Risk indicators for the presence and extent of root caries among caries-active adults enrolled in the Xylitol for Adult Caries Trial (X-ACT).

Authors:  André V Ritter; John S Preisser; Yunro Chung; James D Bader; Daniel A Shugars; Bennett T Amaechi; Sonia K Makhija; Kimberly A Funkhouser; William M Vollmer
Journal:  Clin Oral Investig       Date:  2011-12-24       Impact factor: 3.573

6.  Impact of antipsychotic treatment on nonfasting triglycerides in the CATIE Schizophrenia Trial phase 1.

Authors:  Jonathan M Meyer; Vicki G Davis; Joseph P McEvoy; Donald C Goff; Henry A Nasrallah; Sonia M Davis; Gail L Daumit; John Hsiao; Marvin S Swartz; T Scott Stroup; Jeffrey A Lieberman
Journal:  Schizophr Res       Date:  2008-06-04       Impact factor: 4.939

7.  Inflammatory markers in schizophrenia: comparing antipsychotic effects in phase 1 of the clinical antipsychotic trials of intervention effectiveness study.

Authors:  Jonathan M Meyer; Joseph P McEvoy; Vicki G Davis; Donald C Goff; Henry A Nasrallah; Sonia M Davis; John K Hsiao; Marvin S Swartz; T Scott Stroup; Jeffrey A Lieberman
Journal:  Biol Psychiatry       Date:  2009-07-29       Impact factor: 13.382

8.  ACCORD COPD II: a randomized clinical trial to evaluate the 12-week efficacy and safety of twice-daily aclidinium bromide in chronic obstructive pulmonary disease patients.

Authors:  Stephen I Rennard; Paul D Scanlon; Gary T Ferguson; Ludmyla Rekeda; Brian T Maurer; Esther Garcia Gil; Cynthia F Caracta
Journal:  Clin Drug Investig       Date:  2013-12       Impact factor: 2.859

9.  Effects of pharmacists' interventions on appropriateness of prescribing and evaluation of the instruments' (MAI, STOPP and STARTs') ability to predict hospitalization--analyses from a randomized controlled trial.

Authors:  Ulrika Gillespie; Anna Alassaad; Margareta Hammarlund-Udenaes; Claes Mörlin; Dan Henrohn; Maria Bertilsson; Håkan Melhus
Journal:  PLoS One       Date:  2013-05-17       Impact factor: 3.240

10.  Behavioral characterization of A53T mice reveals early and late stage deficits related to Parkinson's disease.

Authors:  Katrina L Paumier; Stacey J Sukoff Rizzo; Zdenek Berger; Yi Chen; Cathleen Gonzales; Edward Kaftan; Li Li; Susan Lotarski; Michael Monaghan; Wei Shen; Polina Stolyar; Dmytro Vasilyev; Margaret Zaleska; Warren D Hirst; John Dunlop
Journal:  PLoS One       Date:  2013-08-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.